Press release
Chronic Kidney Disease Drugs Market is Estimated to Grow at a CAGR of 4.8% within the forecast period of 2022 to 2030: Cognitive Market Research
Chronic Kidney Disease Drugs Market is Estimated to Grow at a CAGR of 4.8% within the forecast period of 2022 to 2030: Cognitive M
- The progressive loss of kidney function in the body leads to kidney failure and this condition is known as chronic kidney disease. Chronic kidney diseases damage the kidney by building up a high level of fluid, electrolytes, and wastes in the body. This kidney disease deteriorates the function of the kidney and the kidney cannot perform its natural functions properly. The symptoms of chronic kidney disease are sleep problems, vomiting, nausea, loss of appetite, weakness, high blood pressure, and others.
Summary
• North America dominates the global Chronic Kidney Disease Drugs market with the highest revenue share
• The Calcium channel blockers drug class segment dominates the global market with the highest revenue share.
• As per cognitive market research analysts, the Hospitals segment accounted for the largest market share.
To know more The Chronic Kidney Disease Drugs Market statistics click here : https://www.cognitivemarketresearch.com/chronic-kidney-disease-drugs-market-report
Market Dynamics
- The increasing prevalence of chronic kidney disease is forecasted to drive the growth of the global chronic kidney disease drug market. In addition, growing research and development activities in the development of chronic kidney disease drugs are forecasted to dominate the global market. Furthermore, government initiatives for regulatory approvals and favorable insurance policies are forecasted to provide the opportunity for the target market. However, high treatment costs and a lack of awareness about kidney disorders may hamper the growth of the market.
Market Segmentation:
Drug Class:
• ACE Inhibitors
• Angiotensin Receptor Blockers (ARBs)
• B-Blockers
• Calcium Channel Blockers
The Calcium channel blockers drug class segment dominates the global market with the highest revenue share. Calcium channel blockers improve the symptoms in various conditions such as high blood pressure, and coronary artery diseases.
• Loop Diuretics
• Erythropoiesis-Stimulating Agents (ESAs)
• Phosphate Binders
• Others
Route of Administration:
• Oral
As per cognitive market research analysts, the oral segment is forecasted to dominate the global market growth, due to the increased oral drug launches by major market players
• Subcutaneous
• Intravenous
Patient Type:
• Dialysis
• Others
By patient type, the global market is segmented into dialysis and others. The dialysis segment is forecasted to dominate the global chronic kidney disease, due to higher adoption of this treatment for chronic kidney diseases across the globe.
Distribution Channel:
• Hospital Pharmacies
The Hospitals segment accounted for the largest market share, due to the availability of technologically innovative diagnostic equipment for the early diagnosis of the condition.
• Retail Pharmacies
• Online Pharmacies
- Competitive Analysis for Chronic Kidney Disease Drugs Market : Keryx Biopharmaceuticals Inc, Kissei Pharmaceutical Co.Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfize,Others
Get free sample pages of latest published Chronic Kidney Disease Drugs Market Report : https://www.cognitivemarketresearch.com/chronic-kidney-disease-drugs-market-report/report_enquiry/4
Regional analysis
- North America dominates the global chronic kidney disease Drugs market with the highest revenue share. This is attributed to the presence of a majority of the chronic kidney disease drug manufacturers in the region. Furthermore, Asia-Pacific is forecasted to dominate the global market. This is attributed to the large kidney disease patient population and increasing awareness about the disease in the country in the region.
News
• Bayer launched Kerendia (finerenone) for diabetes patients' chronic kidney disease management (CKD)
In August 2022, Bayer launched a finerenone drug to treat chronic kidney disease (CKD) associated with type-2 diabetes in India which is a non-steroidal and selective mineralocorticoid receptor antagonist.
Browse Here For Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Chronic Kidney Disease Drugs Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Chronic Kidney Disease Drugs Market Segmentation
1.5.1 Chronic Kidney Disease Drugs Market Regional Fragmentation
1.5.1 Chronic Kidney Disease Drugs Market Players
• 1.6 Report Duration
Chapter 2 Research MethodologyReview Complete Research Methodology
Chapter 3 Executive Summary of Chronic Kidney Disease Drugs Market
Chapter 4 Global Chronic Kidney Disease Drugs Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Chronic Kidney Disease Drugs Market by Type Segmentation Analysis (2018-2030)
Chapter 9 Global Chronic Kidney Disease Drugs Market by Application Segmentation Analysis (2018-2030)
Chapter 10 Global Chronic Kidney Disease Drugs Market by By Route of Administration Segmentation Analysis (2018-2030)
• 10.1 Detailed Qualitative Analysis
• 10.2 Global Chronic Kidney Disease Drugs Revenue and Share (%) by By Route of Administration (2018-2030)
10.2.1 Oral Market Size
10.2.1.1 Global Oral Market Share and Revenue (USD Million) for 2018-2030
10.2.2 Subcutaneous Market Size
10.2.2.1 Global Subcutaneous Market Share and Revenue (USD Million) for 2018-2030
10.2.3 Intravenous Market Size
10.2.3.1 Global Intravenous Market Share and Revenue (USD Million) for 2018-2030
Chapter 11 Global Chronic Kidney Disease Drugs Market by By Patient Type Segmentation Analysis (2018-2030)
Chapter 12 Global Chronic Kidney Disease Drugs Market by By Distribution Channel Segmentation Analysis (2018-2030)
Chapter 13 Global Chronic Kidney Disease Drugs Market Regional Analysis
Chapter 14 North America Chronic Kidney Disease Drugs Market Outlook (2018 - 2030)
Chapter 15 Europe Chronic Kidney Disease Drugs Market Outlook (2018 - 2030)
Chapter 16 Asia Pacific Chronic Kidney Disease Drugs Market Outlook (2018 - 2030)
Chapter 17 Latin America Chronic Kidney Disease Drugs Market Outlook (2018 - 2030)
Chapter 18 Middle East and Africa Chronic Kidney Disease Drugs Market Outlook (2018 - 2030)
Chapter 19 Research Findings
Customized/Exclusive Report Access on Request
To know more Chronic Kidney Disease Drugs Market TOC click here : https://www.cognitivemarketresearch.com/chronic-kidney-disease-drugs-market-report#table_of_contents
Related Report
• Coronary Artery Disease Therapeutics Market : https://www.cognitivemarketresearch.com/coronary-artery-disease-therapeutics-market-report
• Renal Disease Market : https://www.cognitivemarketresearch.com/Renal-Disease-market-report
• Kidney Stone Therapy Market : https://www.cognitivemarketresearch.com/kidney-stone-therapy-market-report
• Liver Disease Treatment Market : https://www.cognitivemarketresearch.com/liver-disease-treatment-market-report
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us
About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Drugs Market is Estimated to Grow at a CAGR of 4.8% within the forecast period of 2022 to 2030: Cognitive Market Research here
News-ID: 2973079 • Views: …
More Releases from Cognitive Market Research
Ultra Fine Copper Powder Market is estimated to grow at a CAGR of 7.1% during th …
Market Overview:
- The term "ultra-fine copper powder" refers to a finely divided type of copper that is distinguished by its exceedingly small particle size and large surface area. It is made using a variety of processes, such as mechanical grinding, electrolysis, and chemical precipitation. Ultra-fine copper powder typically has particles between a few nanometres and a few micrometers in size.
Summary:
- As per Cognitive Market Research, Global Ultra-Fine Copper…
Premium Branding and Status Symbol boosts the Global Metal Card Market: Cognitiv …
Market Overview:
- A metal card typically refers to a credit or debit card that is made from metal materials instead of traditional plastic. These cards are often associated with premium or high-end credit card offerings and are designed to provide a more luxurious and prestigious feel. Metal cards are usually made from materials such as stainless steel, titanium, or other alloys, which gives them a solid and durable construction.…
Slot Machines Market is projected to grow at a CAGR of 12.9% within the forecast …
Market Overview:
A slot machine is operated by inserting coins into a slot and by pulling down on a long handle. It features a set of spinning reels with various symbols on them. Players or individuals insert coins or tokens into the machine and then pull a lever or press a button to activate the reels. The earliest slot machine technology was created with mechanical reels powered by random number generators.…
Mechanical Seals Market is estimated to grow at a CAGR of 4.8% within the foreca …
Market Overview:
A mechanical seal is only a way to keep fluid inside a vessel usually pumps, mixers, etc. when a rotating shaft passes through a stationary housing or, on rare occasions, when the housing rotates around the shaft. Mechanical seals are devices used to prevent leakage between two components or systems that are connected by a rotating shaft. They are commonly used in pumps, compressors, mixers, and other equipment that…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
